NIH-funded research U01 cooperative agreement

Keeping oxygen in the injured brain after severe head trauma

Official title: Brain Oxygen Optimization in Severe Traumatic Brain Injury - Phase 3 (BOOST-3)

Funded at University of Michigan at Ann Arbor · NIH-11474479 · Data updated 2026-11-12

This project uses a small brain oxygen monitor to guide ICU care for people with severe traumatic brain injury in hopes of improving recovery.

More Brain Injury research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startJuly 1, 2018
Project endFebruary 28, 2029
Funding year2026
Award (this year)$37,500
NIH project number3U01NS099046-06S4
Project IDNIH-11474479 on NIH RePORTER

Who could benefit from this research

Could help

Adults with severe traumatic brain injury who are admitted to an ICU and are eligible for intracranial monitoring may be candidates for this protocol.

Less likely to help

People with mild or chronic brain injury, or those who cannot safely receive an intracranial monitor, are unlikely to be eligible or benefit from this intervention.

What this research studies

If you or a loved one has a severe traumatic brain injury and is in the ICU, doctors would place a tiny probe to measure oxygen levels inside the brain and follow a treatment plan aimed at preventing low brain oxygen. Patients are randomly assigned to care guided by brain tissue oxygen (PbtO2) monitoring versus usual care guided mainly by intracranial pressure (ICP). The team will track brain oxygen episodes, safety, and functional recovery over time at participating trauma centers. This phase 3 effort follows a smaller BOOST phase that reduced brain hypoxia and now aims to see whether that approach leads to better long-term outcomes.

Why it matters

Potential benefit: If successful, this approach could help more people survive severe TBI with better brain function and less disability.

How similar studies have gone: A prior BOOST Phase 2 trial showed a 74% reduction in brain hypoxia and a trend toward improved functional outcomes with no major safety concerns.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Silbergleit, Robert — University of Michigan at Ann Arbor
  • Study coordinator: Silbergleit, Robert

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.